• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds.血红素修饰参与两种末端炔类化合物对人细胞色素P450 2J2基于机制的失活作用。
Drug Metab Dispos. 2017 Sep;45(9):990-999. doi: 10.1124/dmd.117.075846. Epub 2017 Jul 11.
2
Formation of Both Heme and Apoprotein Adducts Contributes to the Mechanism-Based Inactivation of Human CYP2J2 by 17-Ethynylestradiol.血红素和载脂蛋白加合物的形成导致 17-乙炔基雌二醇对人 CYP2J2 的基于机制的失活。
Drug Metab Dispos. 2018 Jun;46(6):813-822. doi: 10.1124/dmd.118.080903. Epub 2018 Mar 30.
3
The inactivation of cytochrome P450 3A5 by 17alpha-ethynylestradiol is cytochrome b5-dependent: metabolic activation of the ethynyl moiety leads to the formation of glutathione conjugates, a heme adduct, and covalent binding to the apoprotein.17α-乙炔雌二醇对细胞色素P450 3A5的失活作用依赖于细胞色素b5:乙炔基部分的代谢活化导致谷胱甘肽缀合物、血红素加合物的形成以及与脱辅基蛋白的共价结合。
J Pharmacol Exp Ther. 2007 Apr;321(1):276-87. doi: 10.1124/jpet.106.117861. Epub 2007 Jan 24.
4
Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein.两种叔丁基炔类化合物对CYP2B1及其F-螺旋突变体的基于机制的失活作用:辅基血红素与脱辅基蛋白的共价修饰
J Pharmacol Exp Ther. 2009 Nov;331(2):392-403. doi: 10.1124/jpet.109.158782. Epub 2009 Aug 21.
5
Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.达那唑以非底物依赖方式抑制细胞色素P450 2J2的活性。
Drug Metab Dispos. 2015 Aug;43(8):1250-3. doi: 10.1124/dmd.115.064345. Epub 2015 Jun 5.
6
Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).米非司酮(RU486)对细胞色素P-450-3A4的基于机制的失活作用
J Pharmacol Exp Ther. 1999 Feb;288(2):791-7.
7
Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites.决奈达隆、胺碘酮及其活性代谢产物对人细胞色素P450 2J2的多种抑制模式。
Biochem Pharmacol. 2016 May 1;107:67-80. doi: 10.1016/j.bcp.2016.03.005. Epub 2016 Mar 10.
8
Cytochrome P450BM-3 (CYP102): regiospecificity of oxidation of omega-unsaturated fatty acids and mechanism-based inactivation.细胞色素P450BM-3(CYP102):ω-不饱和脂肪酸氧化的区域特异性及基于机制的失活
Biochemistry. 1993 Dec 14;32(49):13732-41. doi: 10.1021/bi00212a044.
9
Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.抗高血压药物对人细胞色素 P450 2J2 活性的抑制作用:阿折地平与马尼地平的强烈抑制作用。
Chem Biol Interact. 2019 Jun 1;306:1-9. doi: 10.1016/j.cbi.2019.04.005. Epub 2019 Apr 6.
10
Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.17α-乙炔雌二醇对细胞色素P450 3A4的基于机制的失活:血红素破坏及与蛋白质共价结合的证据
J Pharmacol Exp Ther. 2002 Apr;301(1):160-7. doi: 10.1124/jpet.301.1.160.

引用本文的文献

1
Flipside of the Coin: Iron Deficiency and Colorectal Cancer.硬币的另一面:缺铁与结直肠癌。
Front Immunol. 2021 Mar 11;12:635899. doi: 10.3389/fimmu.2021.635899. eCollection 2021.
2
Acetylenes: cytochrome P450 oxidation and mechanism-based enzyme inactivation.炔烃:细胞色素 P450 氧化和基于机制的酶失活。
Drug Metab Rev. 2019 May;51(2):162-177. doi: 10.1080/03602532.2019.1632891. Epub 2019 Jul 7.
3
Role of Arginine 117 in Substrate Recognition by Human Cytochrome P450 2J2.精氨酸 117 在人细胞色素 P450 2J2 对底物识别中的作用。
Int J Mol Sci. 2018 Jul 16;19(7):2066. doi: 10.3390/ijms19072066.
4
Formation of Both Heme and Apoprotein Adducts Contributes to the Mechanism-Based Inactivation of Human CYP2J2 by 17-Ethynylestradiol.血红素和载脂蛋白加合物的形成导致 17-乙炔基雌二醇对人 CYP2J2 的基于机制的失活。
Drug Metab Dispos. 2018 Jun;46(6):813-822. doi: 10.1124/dmd.118.080903. Epub 2018 Mar 30.

本文引用的文献

1
CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.CYP2J2 和 CYP2C19 是人类肝微粒体和重组 P450 测定系统中负责阿苯达唑和芬苯达唑代谢的主要酶。
Antimicrob Agents Chemother. 2013 Nov;57(11):5448-56. doi: 10.1128/AAC.00843-13. Epub 2013 Aug 19.
2
The effect of ritonavir on human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir.利托那韦对人 CYP2B6 催化活性的影响:血红素修饰导致利托那韦对 CYP2B6 和 CYP3A4 的机制性失活。
Drug Metab Dispos. 2013 Oct;41(10):1813-24. doi: 10.1124/dmd.113.053108. Epub 2013 Jul 25.
3
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.发现并鉴定新型、有效且选择性的细胞色素 P450 2J2 抑制剂。
Drug Metab Dispos. 2013 Jan;41(1):60-71. doi: 10.1124/dmd.112.048264. Epub 2012 Oct 2.
4
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.鉴定 CYP2J2 活性评价的选择性底物和抑制剂对。
Drug Metab Dispos. 2012 May;40(5):943-51. doi: 10.1124/dmd.111.043505. Epub 2012 Feb 10.
5
Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury.环氧二十碳三烯酸可保护大鼠心脏免受肿瘤坏死因子-α诱导的损伤。
J Lipid Res. 2012 Mar;53(3):456-466. doi: 10.1194/jlr.M017319. Epub 2012 Jan 5.
6
Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene.Thr302 是人类细胞色素 P450 2B6 发生共价修饰的位点,导致特丁基苯乙炔的基于机制的失活。
Drug Metab Dispos. 2011 Dec;39(12):2431-9. doi: 10.1124/dmd.111.042176. Epub 2011 Sep 19.
7
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.环氧二十碳三烯酸(EET)拮抗剂抑制癌细胞迁移。
Cancer Sci. 2010 Dec;101(12):2629-36. doi: 10.1111/j.1349-7006.2010.01713.x. Epub 2010 Aug 27.
8
Identification of novel substrates for human cytochrome P450 2J2.鉴定人细胞色素 P450 2J2 的新型底物。
Drug Metab Dispos. 2010 Feb;38(2):347-56. doi: 10.1124/dmd.109.030270. Epub 2009 Nov 18.
9
Cytochrome P450 enzymes and the heart.细胞色素P450酶与心脏
IUBMB Life. 2009 Oct;61(10):954-60. doi: 10.1002/iub.241.
10
Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein.两种叔丁基炔类化合物对CYP2B1及其F-螺旋突变体的基于机制的失活作用:辅基血红素与脱辅基蛋白的共价修饰
J Pharmacol Exp Ther. 2009 Nov;331(2):392-403. doi: 10.1124/jpet.109.158782. Epub 2009 Aug 21.

血红素修饰参与两种末端炔类化合物对人细胞色素P450 2J2基于机制的失活作用。

Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds.

作者信息

Lin Hsia-Lien, Zhang Haoming, Walker Vyvyca J, D'Agostino Jaime, Hollenberg Paul F

机构信息

Department of Pharmacology, University of Michigan, Ann Arbor, Michigan.

Department of Pharmacology, University of Michigan, Ann Arbor, Michigan

出版信息

Drug Metab Dispos. 2017 Sep;45(9):990-999. doi: 10.1124/dmd.117.075846. Epub 2017 Jul 11.

DOI:10.1124/dmd.117.075846
PMID:28698302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5539586/
Abstract

The mechanism-based inactivation of human CYP2J2 by three terminal acetylenic compounds: -(methylsulfonyl)-6-(2-propargyloxyphenyl)hexanamide (MS), 17-octadecynoic acid (OD), and danazol (DZ) was investigated. The loss of hydroxyebastine (OHEB) carboxylation activity in a reconstituted system was time- and concentration-dependent and required NADPH for MS and OD, but not DZ. The kinetic constants for the mechanism-based inactivation of OHEB carboxylation activity were: of 6.1 μM and of 0.22 min for MS and of 2.5 μM and of 0.05 min for OD. The partition ratios for MS and OD were ∼10 and ∼20, respectively. Inactivation of CYP2J2 by MS or OD resulted in a loss of the native heme spectrum and a similar decrease in the reduced CO difference spectrum. A heme adduct was observed in the MS-inactivated CYP2J2. The possible reactive metabolite which covalently modified the prosthetic heme was characterized by analysis of the glutathione conjugates formed by MS or OD following oxygenation of the ethynyl moiety. Liquid chromatography-mass spectrometry showed that inactivation by MS or OD did not lead to modification of apoprotein. Interaction of CYP2J2 with DZ produced a type II binding spectrum with a of 2.8 μM and the IC for loss of OHEB carboxylation activity was 0.18 μM. In conclusion, heme modification by MS and OD was responsible for the mechanism-based inactivation of CYP2J2. The results suggest that the ethynyl moiety of MS and OD faces the heme iron, whereas the isoxazole ring of DZ is preferentially oriented toward the heme iron of CYP2J2.

摘要

研究了三种末端炔类化合物对人细胞色素P450 2J2(CYP2J2)的基于机制的失活作用:-(甲基磺酰基)-6-(2-炔丙氧基苯基)己酰胺(MS)、17-十八碳炔酸(OD)和达那唑(DZ)。在重组系统中,羟基依巴斯汀(OHEB)羧化活性的丧失具有时间和浓度依赖性,MS和OD需要NADPH,但DZ不需要。基于机制的OHEB羧化活性失活的动力学常数为:MS的(K_{I})为6.1 μM,(k_{inact})为0.22 min(^{-1});OD的(K_{I})为2.5 μM,(k_{inact})为0.05 min(^{-1})。MS和OD的分配比分别约为10和20。MS或OD使CYP2J2失活导致天然血红素光谱的丧失以及还原型CO差光谱的类似下降。在MS失活的CYP2J2中观察到血红素加合物。通过分析MS或OD在乙炔基部分氧化后形成的谷胱甘肽缀合物,对共价修饰辅基血红素的可能反应性代谢物进行了表征。液相色谱-质谱分析表明,MS或OD失活不会导致脱辅基蛋白的修饰。CYP2J2与DZ的相互作用产生了II型结合光谱,(K_{d})为2.8 μM,OHEB羧化活性丧失的IC(_{50})为0.18 μM。总之,MS和OD对血红素的修饰是CYP2J2基于机制失活的原因。结果表明,MS和OD的乙炔基部分面向血红素铁,而DZ的异恶唑环优先朝向CYP2J2的血红素铁。